
Lignocip 2% Injection
Marketer
Cipla Ltd
Salt Composition
Lidocaine (2%)
Overview Lignocip 2% Injection
Lignocip 2% Injection provides localized anesthesia for minor surgical interventions, including dental, oral, and other diagnostic or therapeutic procedures. Administered exclusively by medical professionals, it temporarily blocks pain transmission to the brain, ensuring a comfortable procedure. Generally well-tolerated, it may rarely induce mild, transient injection site reactions like soreness, inflammation, or redness. Persistent numbness or other adverse effects necessitate immediate medical attention. Prior to administration, patients with pre-existing cardiac conditions or those using anti-arrhythmic drugs should inform their physician. Pregnant or breastfeeding individuals should seek medical counsel. Drowsiness may occur; therefore, avoid operating vehicles or machinery after injection.
Uses of Lignocip 2% Injection
Regional numbing achieved through localized anesthetic agents.
Major Benefits of Lignocip 2% Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Lignocip 2% Injection:
- Injection site reactions (pain, swelling, redness)
How to use Lignocip 2% Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Lignocip 2% Injection works:
Lignocip 2% Injection provides localized pain relief by interrupting nerve impulses to the brain, thereby reducing pain perception.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Lignocip 2% Injection requires careful consideration. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Lignocip 2% is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Lignocip 2% Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible danger to the infant.
DrivingSAFE
Administration of Lignocip 2% Injection typically does not impair driving ability.
KidneyCAUTION
Administering Lignocip 2% Injection requires careful consideration in individuals with advanced renal impairment. Dosage modification of Lignocip 2% Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should receive Lignocip 2% Injection with close monitoring. Dosage modification of Lignocip 2% Injection may be necessary; physician consultation is advised.
What if you forget to take Lignocip 2% Injection :
NA
Facts to Know About Lignocip 2% Injection
| Label | Value |
|---|---|
| Chemical Category | Amide-based compound |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Action Class | Amide local anesthetics |
